Succinylcholine for electroconvulsive therapy after neuroleptic malignant syndrome: a case report supporting individualised risk assessment. // BJA Open. – URL: https://www.sciencedirect.com/science/article/pii/S2772609626000687?dgcid=rss_sd_all
Succinylcholine for electroconvulsive therapy after neuroleptic malignant syndrome: a case report supporting individualised risk assessment. BJA Open. https://www.sciencedirect.com/science/article/pii/S2772609626000687?dgcid=rss_sd_all
“Succinylcholine for electroconvulsive therapy after neuroleptic malignant syndrome: a case report supporting individualised risk assessment.” BJA Open.
@article{article106850,
title = {Succinylcholine for electroconvulsive therapy after neuroleptic malignant syndrome: a case report supporting individualised risk assessment},
journal = {BJA Open},
url = {https://www.sciencedirect.com/science/article/pii/S2772609626000687?dgcid=rss_sd_all}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...